The massive market transformation this month that some on Wall Street called a "once in a decade opportunity" might have just been a one-off technical move because of taxes.Marketsread more
The Pentagon will deploy U.S. forces to the Middle East on the heels of the attack on Saudi Arabian oil facilities, United States Secretary of Defense Mark Esper announced...Defenseread more
CNBC did a deep dive through the most recent Wall Street research to find stocks that analysts say are underappreciated.Marketsread more
Shares of MasterCard are up 46% this year, and 1120% since 2011, getting a boost from the strong U.S. consumer.Investingread more
CNBC sat in on an "empathy training" at Amazon PillPack's Somerville offices, which is part of new hire orientation.Technologyread more
Trade with China is the 'big unknown' for the Federal Reserve as it decides how best to support the U.S. economy, says Council on Foreign Relations Director of International...Futures Nowread more
Lobbying experts said the visit is likely an attempt to be in lawmakers' ears as they consider legislation that would impact Facebook.Technologyread more
Yardeni Research's Edward Yardeni believes the U.S. economy is picking up steam.Trading Nationread more
Iran's audacious drone and cruise missile attack on Saudi Arabia's oil producing facilities has provided a critical test yet for the Trump administration's foreign policy. A...Politicsread more
Chinese trade negotiators suddenly canceled a visit to meet U.S. farmers after they wrapped up trade talks in Washington this week.Marketsread more
Take a look at some of Monday's midday movers:
JCPenney spiked after the retailer reaffirmed it expects positive comparable store sales in the third quarter.
Bristol-Myers Squibb rose after Morgan Stanley upgraded the stock to "overweight" from "equal weight," citing positive data on their lung cancer drug.
NQ Mobile continued its fall after a negative report by short seller Muddy Waters. Macquarie maintained an "outperform" rating on the stock with a price target of $26 saying it expected the company to report strong earnings on Nov 13.
Facebook fell below $50 a share ahead of its earnings on Wednesday. The WSJ said the company was unable to land a deal to buy photo-sharing social media company Snapchat for $1 billion.
Teva lost ground after the company denied reports its CEO was considering resigning due to a rift with its board of directors.
Edwards Lifesciences moved lower despite reporting better-than-expected third-quarter results as investors focused on the company's weak guidance.
Biogen Idec gained ground after the company posted better-than-expected third-quarter earnings, boosted by sales of its multiple sclerosis drug Tecfidera.
General Electric rose after Credit Suisse raised its price target on the conglomerate to $29 from $27.
Loews fell after the company reported lower adjusted net income for the third quarter, pressured by falling profits from its Diamond Offshore drilling unit.
—By CNBC's Rich Fisherman.
Questions? Comments? Email us at firstname.lastname@example.org